BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28494768)

  • 1. Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.
    Aarts SABM; Seijkens TTP; Kusters PJH; van der Pol SMA; Zarzycka B; Heijnen PDAM; Beckers L; den Toom M; Gijbels MJJ; Boon L; Weber C; de Vries HE; Nicolaes GAF; Dijkstra CD; Kooij G; Lutgens E
    J Neuroinflammation; 2017 May; 14(1):105. PubMed ID: 28494768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis.
    Aarts SA; Seijkens TT; Kusters PJ; van Tiel CM; Reiche ME; den Toom M; Beckers L; van Roomen CP; de Winther MP; Kooij G; Lutgens E
    J Pathol; 2019 Apr; 247(4):471-480. PubMed ID: 30471110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
    Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
    CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
    Valentin-Torres A; Savarin C; Hinton DR; Phares TW; Bergmann CC; Stohlman SA
    J Neuroinflammation; 2016 Feb; 13():46. PubMed ID: 26906225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
    Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG
    J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
    Zhang Z; Zhang ZY; Wu Y; Schluesener HJ
    Neuroscience; 2012 Sep; 221():140-50. PubMed ID: 22800566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NFκB signalling pathway in monocytes.
    Bei JJ; Liu C; Peng S; Liu CH; Zhao WB; Qu XL; Chen Q; Zhou Z; Yu ZP; Peter K; Hu HY
    Thromb Haemost; 2016 Mar; 115(3):632-45. PubMed ID: 26632487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
    Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
    J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
    Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
    J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
    Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
    J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
    Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
    J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity.
    Schreibelt G; Musters RJ; Reijerkerk A; de Groot LR; van der Pol SM; Hendrikx EM; Döpp ED; Dijkstra CD; Drukarch B; de Vries HE
    J Immunol; 2006 Aug; 177(4):2630-7. PubMed ID: 16888025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.